2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(1.61) by 62.73 percent. This is a 76.47 percent increase over losses of $(2.55) per share from the same period last year. The company reported quarterly sales of $56.18 million which beat the analyst consensus estimate of $15.52 million by 261.97 percent. This is a 250.38 percent increase over sales of $16.03 million the same period last year.
Is Now The Right Time To Invest In Nvidia? Fund Managers Are Split: ‘One Of The Hardest Things I’ve Done’
The stock of NVIDIA Corp has been on a rollercoaster ride, with a 240% surge in 2023 and an additional 80% increase in 2024. This has led to a debate among investors on whether to buy now or wait for a potential drop in the stock price.
